These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11469390)
1. Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats. Flint H; Cotter MA; Cameron NE Int J Exp Diabetes Res; 2000; 1(1):49-58. PubMed ID: 11469390 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Cameron NE; Cotter MA; Dines KC; Maxfield EK Diabetologia; 1993 Jun; 36(6):516-22. PubMed ID: 8335173 [TBL] [Abstract][Full Text] [Related]
3. Neurovascular effects of L-carnitine treatment in diabetic rats. Cameron NE; Cotter MA Eur J Pharmacol; 1997 Jan; 319(2-3):239-44. PubMed ID: 9042596 [TBL] [Abstract][Full Text] [Related]
4. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Cameron NE; Cotter MA; Hohman TC Diabetologia; 1996 Feb; 39(2):172-82. PubMed ID: 8635669 [TBL] [Abstract][Full Text] [Related]
5. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen. Cameron NE; Cotter MA; Dines KC; Robertson S; Cox D Br J Pharmacol; 1993 Aug; 109(4):972-9. PubMed ID: 8401950 [TBL] [Abstract][Full Text] [Related]
6. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Cameron NE; Cotter MA; Archibald V; Dines KC; Maxfield EK Diabetologia; 1994 May; 37(5):449-59. PubMed ID: 8056181 [TBL] [Abstract][Full Text] [Related]
7. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats. Cameron NE; Cotter MA Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):685-90. PubMed ID: 9053742 [TBL] [Abstract][Full Text] [Related]
8. Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition. Cotter MA; Ekberg K; Wahren J; Cameron NE Diabetes; 2003 Jul; 52(7):1812-7. PubMed ID: 12829651 [TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats. Dewhurst M; Omawari N; Tomlinson DR Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296 [TBL] [Abstract][Full Text] [Related]
11. Effects of the diacylglycerol complexing agent, cremophor, on nerve-conduction velocity and perfusion in diabetic rats. Jack AM; Cameron NE; Cotter MA J Diabetes Complications; 1999; 13(1):2-9. PubMed ID: 10232703 [TBL] [Abstract][Full Text] [Related]
12. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. Pop-Busui R; Marinescu V; Van Huysen C; Li F; Sullivan K; Greene DA; Larkin D; Stevens MJ Diabetes; 2002 Aug; 51(8):2619-28. PubMed ID: 12145179 [TBL] [Abstract][Full Text] [Related]
13. The effects of 5-hydroxytryptamine 5-HT2 receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats. Cameron NE; Cotter MA Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):607-14. PubMed ID: 12743678 [TBL] [Abstract][Full Text] [Related]
14. Effects of acetyl- and proprionyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes. Cotter MA; Cameron NE; Keegan A; Dines KC Metabolism; 1995 Sep; 44(9):1209-14. PubMed ID: 7666797 [TBL] [Abstract][Full Text] [Related]
15. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism. Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535 [TBL] [Abstract][Full Text] [Related]
16. Correction of neurovascular deficits in diabetic rats by beta2-adrenoceptor agonist and alpha1-adrenoceptor antagonist treatment: interactions with the nitric oxide system. Cotter MA; Cameron NE Eur J Pharmacol; 1998 Feb; 343(2-3):217-23. PubMed ID: 9570470 [TBL] [Abstract][Full Text] [Related]
17. Effects of an extracellular metal chelator on neurovascular function in diabetic rats. Cameron NE; Cotter MA Diabetologia; 2001 May; 44(5):621-8. PubMed ID: 11380081 [TBL] [Abstract][Full Text] [Related]
18. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes. Cameron NE; Cotter MA Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573 [TBL] [Abstract][Full Text] [Related]
19. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats. Cotter MA; Cameron NE; Hohman TC J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252 [TBL] [Abstract][Full Text] [Related]
20. Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Cameron NE; Tuck Z; McCabe L; Cotter MA Diabetologia; 2001 Sep; 44(9):1161-9. PubMed ID: 11596672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]